Poster award for CRL and M4K open science collaboration Congratulations to Senior Scientist Stefano Levanto from Charles River Laboratories (CRL) on winning the early career poster prize for his poster describing CRL's open science collaboration with M4K Pharma at the 20th SCI/RSC Medicinal Chemistry Symposium in Cambridge, UK last month. A team of CRL medicinal chemists [...]
SGC-Oxford team comes out in support of Brain Tumour Charity's Twilight Walk On September 29th 2019, the Brain Tumour Charity organized The Twilight Walk in Warwick, UK, to raise funds for research and patient support. M4K Pharma's DIPG project collaborators at the Structural Genomics Consortium (SGC)- University of Oxford took part in the event by [...]
Collaborators share first ALK2 protein structure bound to M4K Pharma compound A: The overall structure of ALK2 bound to M4K2117. B: The structure of the ligand M4K2117. C: A close up of the binding pocket of ALK2 bound to M4K2117 (From: https://openlabnotebooks.org/deposition-of-structure-of-alk2-with-m4k2117/). M4K Pharma's collaborators Dr Alex Bullock and his team from the Structural Genomics Consortium [...]
Fostering open collaboration in drug development for paediatric brain tumours Wong et al. describe in Biochemical Society Transactions how open collaboration and an open drug discovery model, like the one used by M4K Pharma, can help overcome the challenges faced while researching therapies for rare paediatric brain tumours such as DIPG. Prognosis of childhood brain [...]
Listen to a recording of the Sept 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from September 12th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Listen to a recording of the August 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from August 7th, 2019 where our scientists and collaborators discussed the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Listen to a recording of the July 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from July 3rd, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Listen to a recording of the June 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from June 12th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
M4K Pharma's scientific team of collaborators and partners meets online once a month to present the latest progress in the ALK2 project for DIPG. We will be meeting on the following dates from 10am-12pm EST: June 12th, 2019 July 3rd, 2019 August 7th, 2019 September 4th, 2019 October 2nd, 2019 November 6th, 2019 December 4th, [...]
Listen to a recording of the May 2019 Scientific Update Meeting Listen to M4K Pharma's Scientific Update Meeting from May 8th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
